Today's Rundown Featured Story | | | Wednesday, April 8, 2020 Xerox is partnering with the ventilator manufacturer Vortran to help mass produce its portable, disposable hardware for the COVID-19 pandemic. |
|
|---|
|
Top Stories Tuesday, April 7, 2020 The Trump administration delivered nearly $34 billion in advance and accelerated payments to providers over the past week to help facilities combat COVID-19. Tuesday, April 7, 2020 Roche has stepped on the gas in testing Actemra for coronavirus patients, thanks to a little more help from the U.S. government. BARDA has shelled out $25 million in funding to accelerate the IL-6 inhibitor's phase 3 trial in patients with severe COVID-19 patients. Wednesday, April 8, 2020 “None of the tests we have validated would meet the criteria for a good test," said the University of Oxford's Sir John Bell, citing many false positive and false negative results, and describing an accurate test as potentially weeks away. Wednesday, April 8, 2020 Sanofi and Regeneron are cycling their IL-6 inhibitor Kevzara through clinical trials to treat COVID-19. In the meantime, the drugmakers will put a planned commercial reworking for that drug on the shelf. Tuesday, April 7, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Wednesday, April 8, 2020 Volumes in emergency departments have dropped at many hospitals around the country. But experts warn that could case a different kind of surge when chronic conditions exacerbate. Wednesday, April 8, 2020 During the COVID-19 pandemic, healthcare providers want to talk. So they’re logging onto social media, joining conversations and offering insights more actively than ever before, finds research from CMI/Compas. Specifically, COVID-19 conversations around disease states have increased 1000% among HCPs and 2500% among consumers. Wednesday, April 8, 2020 AstraZeneca has outlined its multipronged approach to the development of antibodies against the pandemic SARS-CoV-2 virus. The Big Pharma is applying its own discovery capabilities to the task and helping to evaluate candidates identified by academic partners in China and the U.S. Wednesday, April 8, 2020 CMS released new and updated guidance for several different types of healthcare facilities to ensure infection control amid the COVID-19 outbreak. Wednesday, April 8, 2020 Soon after CEO Paul Hudson took the reins, Sanofi said it would restructure a long-standing antibody deal with Regeneron. But one of those partnered drugs, the rheumatoid arthritis drug Kevzara, is now in the spotlight as a possible coronavirus treatment—and at least for now, that partnership stands. Wednesday, April 8, 2020 America's Essential Hospitals is concerned about the method CMS is using to disperse $30B in grant funding to providers, but more help is on the way. Wednesday, April 8, 2020 Though diagnostics are not one of their core research efforts, the drugmakers AstraZeneca and GlaxoSmithKline are looking to assist the U.K. government’s national COVID-19 testing efforts by establishing a joint lab at the University of Cambridge. Wednesday, April 8, 2020 As COVID-19 continues to wreak havoc across nearly all clinical trials in the U.S., Asia and Europe, so-called virtual trials are coming to the fore. Now, PPD is teaming up with Science 37 to tap its “siteless” approach to trials. Wednesday, April 8, 2020 Scientists have been using viruses to deliver gene therapies or vaccines. Now, researchers at the University of Iowa and the University of Georgia are suggesting the virus that causes kennel cough in dogs could be used in the construct of vaccines against COVID-19. |
|
